 |
|
Diabetic kidney disease treatment: new perspectives
Li-Li Tong, Sharon G. Adler
Kidney Res Clin Pract. 2022;41(Suppl 2):S63-S73. Published online 2022 Sep 30 DOI: https://doi.org/10.23876/j.krcp.21.288
|
|
Citations to this article as recorded by
 Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline
Yuqing Chen, Federico Torta, Hiromi W. L. Koh, Peter I. Benke, Resham L. Gurung, Jian-Jun Liu, Keven Ang, Yi-Ming Shao, Gek Cher Chan, Jason Chon-Jun Choo, Jianhong Ching, Jean-Paul Kovalik, Tosha Kalhan, Rajkumar Dorajoo, Chiea Chuen Khor, Yun Li, Wern E
Diabetologia.2025; 68(3): 557. CrossRef Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials
Sieta T. de Vries, Michelle J. Pena, Sok Cin Tye, Sanne A. E. Peters, Daniël H. van Raalte, Clare Arnott, Adriaan A. Voors, Peter G. M. Mol, Petra Denig, Hiddo J. L. Heerspink
Diabetologia.2025; 68(3): 507. CrossRef Assessment of effects of combination of SGLT2 inhibitors and renin–angiotensin–aldosterone system blockers on the renal functions of patients of diabetic kidney disease (SGRASS-DKD study)
Susovan Halder, Arnab Bhattacharyya, Shatavisa Mukherjee, Bhaswar Konar, Antareep Halder
Journal of Diabetology.2024; 15(1): 79. CrossRef The Mechanism of Plantaginis Semen in the Treatment of Diabetic
Nephropathy based on Network Pharmacology and Molecular Docking
Technology
Linlin He, Kai Shen, Lei He, Yuqing Chen, Zhiyuan Tang
Endocrine, Metabolic & Immune Disorders - Drug Targets.2024; 24(3): 363. CrossRef Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions
Rajesh Jha, Sara Lopez-Trevino, Haritha R. Kankanamalage, Jay C. Jha
Biomedicines.2024; 12(5): 1098. CrossRef The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease
Meiyan Wu, Chang-Yun Yoon, Jimin Park, Gyuri Kim, Bo Young Nam, Seonghun Kim, Jung Tak Park, Seung Hyeok Han, Shin-Wook Kang, Tae-Hyun Yoo
Diabetologia.2024; 67(9): 1980. CrossRef Blood pressure control in diabetic kidney disease: a post-hoc analysis of the FANTASTIC trial
Cheol Ho Park, Soon Jun Hong, Sung Gyun Kim, Seok Joon Shin, Dong Ki Kim, Jung Pyo Lee, Sang Youb Han, Sangho Lee, Jong Chul Won, Young Sun Kang, Jongha Park, Byoung-Geun Han, Ki-Ryang Na, Kyu Yeon Hur, Yong-Jin Kim, Sungha Park, Tae-Hyun Yoo
Clinical Hypertension.2024;[Epub] CrossRef Multicentre, retrospective cohort study protocol to identify racial and ethnic differences in acute kidney injuries in children and adolescents with diabetic ketoacidosis
Kelly R Bergmann, Petter Bjornstad, M Jennifer Abuzzahab, Ling Zhong, Elizabeth Collins-Dippel, Amanda Nickel, Dave Watson, Anupam Kharbanda
BMJ Open.2024; 14(6): e086261. CrossRef Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The
Lisa Chu, Ryan M. Bradley, Pernille Auerbach, Alexander Abitbol
Diabetes, Obesity and Metabolism.2024; 26(10): 4674. CrossRef Comprehensive insights into diabetic nephropathy: pathophysiology, clinical features, and emerging treatments
Mohamad M. Habli
Journal of The Egyptian Society of Nephrology and Transplantation.2024; 24(4): 163. CrossRef Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Advanced Chronic Kidney Disease
Cheol Ho Park, Hyunsun Lim, Youn Nam Kim, Jae Young Kim, Hyung Woo Kim, Tae Ik Chang, Seung Hyeok Han
American Journal of Nephrology.2024; : 1. CrossRef Unveiling the utility of artificial intelligence for prediction, diagnosis, and progression of diabetic kidney disease: an evidence-based systematic review and meta-analysis
Sagar Dholariya, Siddhartha Dutta, Amit Sonagra, Mehul Kaliya, Ragini Singh, Deepak Parchwani, Anita Motiani
Current Medical Research and Opinion.2024; 40(12): 2025. CrossRef Steps to understanding diabetes kidney disease: a focus on metabolomics
Hyo Jin Kim, Sang Heon Song
The Korean Journal of Internal Medicine.2024; 39(6): 898. CrossRef A New Era in Diabetic Kidney Disease Treatment: The Four Pillars and Strategies to Build Beyond
Sangyub Han, Sejoong Kim
Electrolytes & Blood Pressure.2024; 22(2): 21. CrossRef Naringin abrogates angiotensin-converting enzyme (ACE) activity and podocin signalling pathway in cobalt chloride-induced nephrotoxicity and hypertension
Ademola Adetokunbo Oyagbemi, Temitayo Olabisi Ajibade, Oluwaseun Olanrewaju Esan, Moses Olusola Adetona, Ayobami Deborah Obisesan, Adewumi Victoria Adeogun, Omolola Victoria Awoyomi, Joseph Ayotunde Badejo, Aduragbenro Deborah A. Adedapo, Temidayo Olutayo
Biomarkers.2023; 28(2): 206. CrossRef Impact of albuminuria on the various causes of death in diabetic patients: a nationwide population-based study
Semin Cho, Hyuk Huh, Sehoon Park, Soojin Lee, Sehyun Jung, Minsang Kim, Kyu-na Lee, Jin Hyuk Paek, Woo Yeong Park, Kyubok Jin, Seungyeup Han, Kwon Wook Joo, Chun Soo Lim, Yon Su Kim, Kyungdo Han, Yaerim Kim, Dong Ki Kim
Scientific Reports.2023;[Epub] CrossRef Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT
Ara Cho, Wencheng Jin, Jeonghwan Lee, Nayeon Shin, Myoung Seok Lee, Lilin Li, Seung Hee Yang, Kyong Soo Park, Chul Woo Yang, Dong Ki Kim, Yun Kyu Oh, Chun Soo Lim, Jung Pyo Lee
Scientific Reports.2023;[Epub] CrossRef Virtual diagnosis of diabetic nephropathy using metabolomics in place of kidney biopsy: The DIAMOND study
Da Woon Kim, Hyo Jin Kim, Eun Young Seong, Sang Soo Kim, Sujin Lee, Suhkmann Kim, Chae Hwa Kwon, Sang Heon Song
Diabetes Research and Clinical Practice.2023; 205: 110986. CrossRef
|